Podcasts about comorbid

Psychogenic nonepileptic seizures (PNES) are common, often misunderstood, and increasingly encountered in pediatric emergency care. These events closely resemble epileptic seizures but arise from abnormal brain network functioning rather than epileptiform activity. In this episode of PEM Currents, we review the epidemiology, pathophysiology, and clinical features of PNES in children and adolescents, with a practical focus on Emergency Department recognition, diagnostic strategy, and management. Particular emphasis is placed on seizure semiology, avoiding iatrogenic harm, communicating the diagnosis compassionately, and understanding how early identification and referral to cognitive behavioral therapy can dramatically improve long-term outcomes. Learning Objectives Identify key epidemiologic trends, risk factors, and semiological features that help differentiate psychogenic nonepileptic seizures from epileptic seizures in pediatric patients presenting to the Emergency Department. Apply an evidence-based Emergency Department approach to the evaluation and initial management of suspected PNES, including strategies to avoid unnecessary escalation of care and medication exposure. Demonstrate effective, patient- and family-centered communication techniques for explaining the diagnosis of PNES and facilitating timely referral to appropriate outpatient therapy. References Sawchuk T, Buchhalter J, Senft B. Psychogenic Nonepileptic Seizures in Children-Prospective Validation of a Clinical Care Pathway & Risk Factors for Treatment Outcome. Epilepsy & Behavior. 2020;105:106971. (PMID: 32126506) Fredwall M, Terry D, Enciso L, et al. Outcomes of Children and Adolescents 1 Year After Being Seen in a Multidisciplinary Psychogenic Nonepileptic Seizures Clinic. Epilepsia. 2021;62(10):2528-2538. (PMID: 34339046) Sawchuk T, Buchhalter J. Psychogenic Nonepileptic Seizures in Children - Psychological Presentation, Treatment, and Short-Term Outcomes. Epilepsy & Behavior. 2015;52(Pt A):49-56. (PMID: 26409129) Labudda K, Frauenheim M, Miller I, et al. Outcome of CBT-based Multimodal Psychotherapy in Patients With Psychogenic Nonepileptic Seizures: A Prospective Naturalistic Study. Epilepsy & Behavior. 2020;106:107029. (PMID: 32213454) Transcript This transcript was generated using Descript automated transcription software and has been reviewed and edited for accuracy by the episode's author. Edits were limited to correcting names, titles, medical terminology, and transcription errors. The content reflects the original spoken audio and was not substantively altered. Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I'm your host, Brad Sobolewski, and today we are talking about psychogenic non-epileptic seizures, or PNES. Now, this is a diagnosis that often creates a lot of uncertainty in the Emergency Department. These episodes can be very scary for families and caregivers and schools. And if we mishandle the diagnosis, it can lead to unnecessary testing, medication exposure, ICU admissions, and long-term harm. This episode's gonna focus on how to recognize PNES in pediatric patients, how we make the diagnosis, what the evidence says about management and outcomes, and how what we do and what we say in the Emergency Department directly affects patients, families, and prognosis. Psychogenic non-epileptic seizures are paroxysmal events that resemble epileptic seizures but occur without epileptiform EEG activity. They're now best understood as a subtype of functional neurological symptom disorder, specifically functional or dissociative seizures. Historically, these events were commonly referred to as pseudo-seizures, and that term still comes up frequently in the ED, in documentation, and sometimes from families themselves. The problem is that pseudo implies false, fake, or voluntary, and that implication is incorrect and harmful. These episodes are real, involuntary, and distressing, even though they're not epileptic. Preferred terminology includes psychogenic non-epileptic seizures, or PNES, functional seizures, or dissociative seizures. And PNES is not a diagnosis of exclusion, and it does not require identification of psychological trauma or psychiatric disease. The diagnosis is based on positive clinical features, ideally supported by video-EEG, and management begins with clear, compassionate communication. The overall incidence of PNES shows a clear increase over time, particularly from the late 1990s through the mid-2010s. This probably reflects improved recognition and access to diagnostic services, though a true increase in occurrence can't be excluded. Comorbidity with epilepsy is really common and clinically important. Fourteen to forty-six percent of pediatric patients with PNES also have epilepsy, which frequently complicates diagnosis and contributes to diagnostic delay. Teenagers account for the highest proportion of patients with PNES, especially 15- to 19-year-olds. Surprisingly, kids under six are about one fourth of all cases, so it's not just teenagers. We often make the diagnosis of PNES in epilepsy monitoring units. So among children undergoing video-EEG, about 15 to 19 percent may ultimately be diagnosed with PNES. And paroxysmal non-epileptic events in tertiary epilepsy monitoring units account for about 15 percent of all monitored patients. Okay, but what is PNES? Well, it's best understood as a disorder of abnormal brain network functioning. It's not structural disease. The core mechanisms at play include altered attention and expectation, impaired integration of motor control and awareness, and dissociation during events. So the patients are not necessarily aware that this is happening. Psychological and psychosocial features are common but not required for diagnosis and may be less prevalent in pediatric populations as compared with adults. So PNES is a brain-based disorder. It's not conscious behavior, it's not malingering, and it's not under voluntary control. Children and adolescents with PNES have much higher rates of psychiatric comorbidities and psychosocial stressors compared to both healthy controls and children with epilepsy alone. Psychiatric disorders are present in about 40 percent of pediatric PNES patients, both before and after the diagnosis. Anxiety is seen in 58 percent, depression in 31 percent, and ADHD in 35 percent. Compared to kids with epilepsy, the risk of psychiatric disorders in PNES is nearly double. Compared to healthy controls, it is up to eight times higher. And there's a distinct somatopsychiatric profile that strongly predicts diagnosis of PNES. This includes multiple medical complaints, psychiatric symptoms, high anxiety sensitivity, and solitary emotional coping. This profile, if you've got all four of them, carries an odds ratio of 15 for PNES. Comorbid epilepsy occurs in 14 to 23 percent of pediatric PNES cases, and it's associated with intellectual disability and prolonged diagnostic delay. And finally, across all demographic strata, anxiety is the most consistent predictor of PNES. Making the diagnosis is really hard. It really depends on a careful history and detailed analysis of the events. There's no single feature that helps us make the diagnosis. So some of the features of the spells or events that have high specificity for PNES include long duration, so typically greater than three minutes, fluctuating or asynchronous limb movements, pelvic thrusting or side-to-side head movements, ictal eye closure, often with resisted eyelid opening, ictal crying or vocalization, recall of ictal events, and rare association with injury. Younger children often present with unresponsiveness. Adolescents more commonly demonstrate prominent motor symptoms. In pediatric cohorts, we most frequently see rhythmic motor activity in about 27 percent, and complex motor movements and dialeptic events in approximately 18 percent each. Features that argue against PNES include sustained cyanosis with hypoxia, true lateral tongue biting, stereotyped events that are identical each time, clear postictal confusion or lethargy, and obviously epileptic EEG changes during the events themselves. Now there are some additional historical and contextual clues that can help us make the diagnosis as well. If the events occur in the presence of others, if they occur during stressful situations, if there are psychosocial stressors or trauma history, a lack of response to antiepileptic drugs, or the absence of postictal confusion, this may suggest PNES. Lower socioeconomic status, Medicaid insurance, homelessness, and substance use are also associated with PNES risk. While some of these features increase suspicion, again, video-EEG remains the diagnostic gold standard. We do not have video-EEG in the ED. But during monitoring, typical events are ideally captured and epileptiform activity is not seen on the EEG recording. Video-EEG is not feasible for every single diagnosis. You can make a probable PNES diagnosis with a very accurate clinical history, a vivid description of the signs and appearance of the events, and reassuring interictal EEG findings. Normal labs and normal imaging do not make the diagnosis. Psychiatric comorbidities are not required. The diagnosis, again, rests on positive clinical features. If the patient can't be placed on video-EEG in a monitoring unit, and if they have an EEG in between events and it's normal, that can be supportive as well. So what if you have a patient with PNES in the Emergency Department? Step one, stabilize airway, breathing, circulation. Take care of the patient in front of you and keep them safe. Use seizure pads and precautions and keep them from falling off the bed or accidentally injuring themselves. A family member or another team member can help with this. Avoid reflexively escalating. If you are witnessing a PNES event in front of you, and if they're protecting their airway, oxygenating, and hemodynamically stable, avoid repeated benzodiazepines. Avoid intubating them unless clearly indicated, and avoid reflexively loading them with antiseizure medications such as levetiracetam or valproic acid. Take a focused history. You've gotta find out if they have a prior epilepsy diagnosis. Have they had EEGs before? What triggered today's event? Do they have a psychiatric history? Does the patient have school stressors or family conflict? And then is there any recent illness or injury? Only order labs and imaging when clinically indicated. EEG is not widely available in the Emergency Department. We definitely shouldn't say things like, “this isn't a real seizure,” or use outdated terms like pseudo-seizure. Don't say it's all psychological, and please do not imply that the patient is faking. If you see a patient and you think it's PNES, you're smart, you're probably right, but don't promise diagnostic certainty at first presentation. Remember, a sizable proportion of these patients actually do have epilepsy, and referring them to neurology and getting definitive testing can really help clarify the diagnosis. Communication errors, especially early on, worsen outcomes. One of the most difficult things is actually explaining what's going on to families and caregivers. So here's a suggestion. You could say something like: “What your child is experiencing looks like a seizure, but it's not caused by abnormal electrical activity in the brain. Instead, it's what we call a functional seizure, where the brain temporarily loses control of movement and awareness. These episodes are real and involuntary. The good news is that this condition is treatable, especially when we address it early.” The core treatment of PNES is CBT-based psychotherapy, or cognitive behavioral therapy. That's the standard of care. Typical treatment involves 12 to 14 sessions focused on identifying triggers, modifying maladaptive cognitions, and building coping strategies. Almost two thirds of patients achieve full remission with treatment. About a quarter achieve partial remission. Combined improvement rates reach up to 90 percent at 12 months. Additional issues that neurologists, psychologists, and psychiatrists often face include safe tapering of antiseizure medications when epilepsy has been excluded, treatment of comorbid anxiety or depression, coordinating care between neurology and mental health professionals, and providing education for schools on event management. Schools often witness these events and call prehospital professionals who want to keep patients safe. Benzodiazepines are sometimes given, exposing patients to additional risk. This requires health system-level and outpatient collaboration. Overall, early diagnosis and treatment of PNES is critical. Connection to counseling within one month of diagnosis is the strongest predictor of remission. PNES duration longer than 12 months before treatment significantly reduces the likelihood of remission. Video-EEG confirmation alone does not predict positive outcomes. Not every patient needs admission to a video-EEG unit. Quality of communication and speed of treatment, especially CBT-based therapy, matter the most. Overall, the prognosis for most patients with PNES is actually quite favorable. There are sustained reductions in events along with improvements in mental health comorbidities. Quality of life and psychosocial functioning improve, and patients use healthcare services less frequently. So here are some take-home points about psychogenic non-epileptic seizures, or PNES. Pseudo-seizure and similar terms are outdated and misleading. Do not use them. PNES are real, involuntary, brain-based events. Diagnosis relies on positive clinical features, what the events look like and when they happen, not normal lab tests or CT scans. Early recognition and diagnosis, and rapid referral to cognitive behavioral therapy, change patients' lives. If you suspect PNES, get neurology and mental health professionals involved as soon as possible. Alright, that's all I've got for this episode. I hope you found it educational. Having seen these events many times over the years, I recognize how scary they can be for families, schools, and our prehospital colleagues. It's up to us to think in advance about how we're going to talk to patients and families and develop strategies to help children who are suffering from PNES events. If you've got feedback about this episode, send it my way. Likewise, like, rate, and review, as my teenagers would say, and share this episode with a colleague if you think it would be beneficial. For PEM Currents: The Pediatric Emergency Medicine Podcast, this has been Brad Sobolewski. See you next time.

In this episode, we explore how Lurasidone at lower doses (20-60 mg/day) effectively treats both depression and anxiety in bipolar I disorder. Why does the lower dose range outperform higher doses for patients with severe anxiety? Discover the surprising dose-dependent effects and metabolic advantages that make this a game-changer. Faculty: Kristin Raj, M.D. Host: Richard Seeber, M.D. Learn more about our membership here. Earn 0.75 CMEs: Quick Take Vol. 77 Is Lurasidone Effective for Bipolar Depression with Comorbid Anxiety?

SEASON 6 of Emetophobia Help TRIGGER WARNING: Words such as "vomit,” “throw up” and "sick" may be used. Host: Anna Christie, Psychotherapist and Emetophobia SpecialistGuest: Liz Sinclair11 Emetophobia CLASSES with Anna: www.emetophobiahelp.org/classesFacebook Group: Emetophobia NO PANICANNA & DAVID'S BOOK: Emetophobia: Understanding and Treating Fear of Vomiting in Children and Adults: Russ, David, Dr., Christie, Anna S., FOR KIDS: "Turnaround Anxiety Program" with Emetophobia supplement (McCarthy/Russ) and  Emetophobia! The Ultimate Kids' Guide eBook : Russ. PhD, DavidBuy Me a Coffeehttps://buymeacoffee.com/emethelpIntro Music: YouTube Audio Library, "Far Away (Sting)" by MK2, Used with Permission.Support the showAnna's Website: www.emetophobiahelp.orgResource site for Clinicians: www.emetophobia.netMERCH for stress, anxiety, panic: www.katralex.com

In this episode, host Alyssa Watson, DVM, welcomes back Tamara Grubb, DVM, PhD, DACVAA, to talk about her recent Clinician's Brief article, “Managing Fractious Patients with Comorbid Disease.” Dr. Grubb discusses why sedation is helpful, effective drug selection, and ideal timing. She even provides some useful tips, such as the “injecting while walking” technique.Resources:https://www.cliniciansbrief.com/article/fas-dogs-cats-sedationhttps://www.simparicatriodvm.comContact:podcast@instinct.vetWhere To Find Us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/Instagram: @Clinicians.BriefX: @CliniciansBriefThe Team:Alyssa Watson, DVM - HostAlexis Ussery - Producer & Multimedia Specialist

Published through Substack | Available on all platformsHey ADHDers—ever canceled plans because your brain gave you a headache? (Yeah, same.)In this BONUS episode of Authentically ADHD, Carmen—your coach, teacher, and fellow neurospicy human—dives headfirst into the wild connection between ADHD and headaches. Spoiler alert: It's not all in your head… unless we're talking about dopamine dysfunction, sensory overload, and sleep-deprived executive dysfunction (in which case, it absolutely is).

Episode 192: ADHD Treatment.  Jordan Redden (MSIV) explains the treatment of ADHD. Dr. Bustamante adds input about pharmacologic and non-pharmacologic treatments. Dr. Arreaza shares the how stimulants were discovered as the treatment for ADHD. Written by Jordan Redden, MSIV, Ross University School of Medicine. Comments and edits by Isabelo Bustamante, MD, and Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction.ADHD is a chronic neurodevelopmental condition characterized by inattention, impulsivity, and/or hyperactivity. While it's often diagnosed in childhood, symptoms can persist well in adulthood. The treatment for ADHD is multifaceted. It often includes medication, behavioral therapy, environmental modifications, and sometimes educational interventions which are especially effective in younger patients. Ongoing evaluation is needed during treatment. Treatment needs adjustments over time.Starting with medications: Stimulants are the most well-studied and effective pharmacologic treatment for ADHD. These include methylphenidate-based medications such as Ritalin, Concerta, and Focalin, and amphetamine-based options, like Adderall, Vyvanse, and Dexedrine. Discovery of stimulants for ADHD> Dr. Charles Bradley discovered stimulants as the treatment for ADHD around 1937. ADHD did not have a name at that time, but it was known that some children had behavioral problems related to poor attention and inability to control their impulses, but they were still intelligent. Dr. Bradley was a psychiatrist who was working in the Bradley Hospital (Rhode Island), he was studying these children and, as part of his experiments, they developed severe headaches. He gave “Benzedrine” (a decongestant) to his pediatric patients to treat severe headaches, and he discovered that Benzedrine improved academic performance and interest in school and improved disruptive behavior in some children.How do stimulants work.Stimulants work primarily by increasing dopamine and norepinephrine levels in the brain, which helps improve focus, attention span, and impulse control. They typically show a rapid onset of action and can lead to noticeable improvements within the first few days of use. Dosing is individualized and should start low with gradual titration. Side effects can include reduced appetite, insomnia, headaches, increased heart rate, and emotional lability.Types of stimulants. Stimulants come as short acting and long acting. They can come as a tablet, liquid, patch, or orally disintegrating tablet. After the discovery of Benzedrine as a possible treatment for ADHD, more research was done over the years, and Ritalin became the first FDA-approved medication for ADHD (1955). The list of medications may seem overwhelming, but there are only two types of stimulants used to treat ADHD: methylphenidate and amphetamine. Long-acting stimulant medications are often preferred for their consistent symptom control and lower potential for misuse. Vyvanse (lis-dexa-mfetamine) is a widely used long-acting amphetamine-based option. As a prodrug, it remains inactive until metabolized in the body, which results in a smoother onset and offset of action and may reduce the risk of abuse. This extended duration of effect can help patients maintain focus and regulate impulses throughout the day without the peaks and crashes sometimes seen with shorter-acting formulations. Of note, Vyvanse is also approved for Binge Eating Disorder. Many of these medications are Schedule II controlled substances, so to prescribe them you need a DEA license. Other long-acting options include Concerta, an extended-release methylphenidate, as well as extended-release versions of Adderall and Focalin. These are especially helpful for school-aged children who benefit from once-daily dosing, and for adults who need sustained attention during work or academic activities. The choice between short- and long-acting stimulants depends on individual response, side effect tolerance, and daily routine.For patients who cannot tolerate stimulants, or for those with contraindications such as a history of substance misuse or certain cardiac conditions, non-stimulant medications are an alternative. One of the most used is atomoxetine, which inhibits the presynaptic norepinephrine transporter (NET). This leads to increased levels of norepinephrine (and to a lesser extent dopamine). Guanfacine or clonidine are alpha-2A adrenergic receptor agonists that lead to reduced sympathetic outflow and enhanced prefrontal cortical function, improving attention and impulse control. These alpha agonists are particularly useful in younger children with significant hyperactivity or sleep disturbances.Non-pharmacologic treatments.Behavioral therapy before age 6 is the first choice, after that, medications are more effective than BH only, and as adults again you use CBT.Medication is often just one part of a broader treatment plan. Behavioral therapy, especially in children, plays a critical role. Parent-training programs, positive reinforcement systems, and structured routines can significantly improve functioning. And for adolescents and adults, cognitive-behavioral therapy (CBT) is particularly helpful. CBT can address issues like procrastination, time management, emotional regulation, and self-esteem which are areas that medication doesn't always touch.Using medications for ADHD can be faced with resistance by parents, and even children. There is stigma and misconceptions about mental health, there may be concerns about side effects, fear of addiction, negative past experiences, and some parents prefer to treat ADHD the “natural” way without medications or only with supplements. All those concerns are valid. Starting a medication for ADHD is the first line of treatment in children who are 6 years and older, but it requires a shared decision with parents and patients. Cardiac side effects are possible with stimulants. EKG may be needed before starting stimulants, but it is not required. Get a personal and family cardiac history, including a solid ROS. Benefits include control of current condition and treating comorbid conditions.The presentation of ADHD changes as the person goes through different stages of life. For example, you may have severe hyperactivity in your school years, but that hyperactivity improves during adolescence and impulsivity worsens. It varies among sexes too. Women tend to present as inattentive, and men tend to be more hyperactive. ADHD is often underdiagnosed in adults, yet it can significantly impact job performance, relationships, and mental health. In adults, we often use long-acting stimulants to minimize the potential for misuse. And psychotherapy, particularly CBT or executive functioning coaching, can be life-changing when combined with pharmacologic treatment. There are several populations where treatment must be tailored carefully such as pregnant patients, individuals with co-occurring anxiety or depression, and those with a history of substance use. For example, atomoxetine may be preferred in patients with a history of substance misuse. And in children with coexisting oppositional defiant disorder, combined behavioral and pharmacologic therapy is usually more effective than either approach alone.Comorbid conditions.Depression and anxiety can be comorbid, and they can also mimic ADHD. Consult your DSM-5 to clarify what you are treating, ADHD vs depression/anxiety.Treatment goes beyond the clinic. For school-aged children, we often work closely with schools to implement 504 plans or Individualized Education Programs (IEPs) that provide classroom accommodations. Adults may also benefit from workplace strategies like structured schedules, noise-reducing headphones, or even coaching support. Ongoing monitoring is absolutely essential. We assess side effects of medication, adherence, and symptom control. ***In children, we also monitor growth and sleep patterns. We often use validated rating scales, like the Vanderbilt questionnaire for children 6–12 (collect answers from two settings) or Conners questionnaires (collect from clinician, parents and teachers), to track progress. And shared decision-making with patients and families is key throughout the treatment process.To summarize, ADHD is a chronic but manageable condition. Effective treatment usually involves a combination of medication and behavioral interventions, tailored to the individual's needs. And early diagnosis and treatment can significantly improve quality of life academically, socially, and emotionally.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text rev. (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022. CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder). Understanding ADHD. Accessed May 2025. https://chadd.org National Institute for Health and Care Excellence (NICE). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE guideline [NG87]. Updated March 2018. Accessed May 2025. https://www.nice.org.uk/guidance/ng87 Pliszka SR; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724 Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 Texas Children's Hospital. ADHD Provider Toolkit. Baylor College of Medicine. Accessed May 2025. https://www.bcm.edu Wolraich ML, Hagan JF Jr, Allan C, et al. Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis. UpToDate. Published 2024. Accessed May 2025.https://www.uptodate.comThe History of ADHD and Its Treatments, https://www.additudemag.com/history-of-adhd/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Expect rising comorbidity of OSA and insomnia Avoid prescribing sedatives in patients with OSA and insomnia Cognitive hehavioural therapy for insomnia (CBT-I) is the first-line treatment for insomnia Support patient adherence to continuous positive airway pressure (CPAP) early Habits are fragile but re-trainable Host: Dr David Lim | Total Time: 50 mins Expert: Dr Rosemary Clancy, Clinical Psychologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

ADHD often doesn't play alone. In this week's episode Patty shares some common co-existing conditions. Also, Patty has a an ADHD-friendly product to highlight that she has been using for years!PLUS: Hear this week's pick for Book of the Week!ADHD-Friendly Membership has a new Hybrid Course: ADHDU! Click the link below for more info:https://www.adhdfriendly.com/adhd-friendly-all-access-membership-includes/The ADHD-Friendly Planner On-Demand Course PLUS Planner is available in the ADHD-Friendly shop for only $79.95: https://www.adhdfriendly.com/adhd-friendly-shop/Thank you for checking out this episode of the ADHD Friendly podcast with Patty Blinderman!!New episodes are posted every Wednesday! Subscribe to the channel here: https://www.youtube.com/@adhdfriendlyCheck out/Join the ADHD-Friendly membership here: https://www.adhdfriendly.com/adhd-friendly-all-access-membership-includes/Please subscribe to my YouTube channel, ADHD Friendly Podcast, or wherever you listen to podcasts. For more information on the ADHD-Friendly services offered by Patty, please visit her website: ADHDFriendly.com

ADHD doesn't just complicate relationships—it shapes them. From romantic partnerships to friendships, family dynamics, and workplace interactions, the traits of inattention, impulsivity, and hyperactivity ripple across every connection. Romantic relationships often bear the brunt, with ADHD symptoms leading to miscommunication, frustration, and even intimacy challenges. Couples may struggle with mismatched libidos, impulsive behaviors, or emotional dysregulation, but understanding ADHD's role can transform these struggles into opportunities for deeper connection.Family and professional relationships, too, are affected. ADHD parents often wrestle with providing structure or consistent discipline, creating chaotic home environments that strain relationships with children and partners. At work, impulsivity, time management issues, and difficulty following through on commitments can complicate team dynamics and career growth. Socially, the ADHD brain's challenges with focus and emotional regulation can lead to feelings of rejection or isolation, making it harder to build and sustain friendships.The science behind these struggles lies in the ADHD brain itself. Impaired dopamine regulation impacts empathy, social cognition, and emotional recognition, all of which play critical roles in relationships. Comorbid conditions like anxiety, depression, or substance use disorders further complicate matters, while genetic factors often ripple across generations, creating patterns of behavior that shape family and social dynamics. But the good news? With the right diagnosis, treatment, and tools, ADHDers can overcome these challenges and thrive in their relationships.In this episode, Nikki Kinzer and Pete Wright explore the intersection of ADHD and relationships, unpacking the science, the stories, and the strategies that foster connection. From structured communication techniques to empathy-building exercises, they offer actionable advice to help ADHDers and their loved ones navigate challenges and unlock the unique strengths ADHD brings to relationships. Whether you're navigating romance, family life, or professional interactions, this episode is a must-listen for anyone seeking to better understand ADHD's role in human connection.Links & NotesSupport the Show on PatreonDig into the podcast Shownotes Database (00:00) - Welcome to Taking Control: The ADHD Podcast (02:29) - ADHD Relationships ★ Support this podcast on Patreon ★

Treatment of hepatocellular carcinoma (HCC), like that of many other cancers, spans a spectrum from curative to palliative intent. To explore the "grey zone" of treatment goals for intermediate-stage HCC patients, Dr. Sabeen Dhand interviews a panel of experts in the field: medical oncologists Dr. Adam Burgoyne and Dr. Lingling Du, along with interventional radiologists Dr. Kirema Garcia-Reyes and Dr. Zachary Berman. Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion: https://www.cmeuniversity.com/course/take/125739 --- This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific. --- SYNPOSIS The discussion begins with an explanation of the Barcelona-Clinic Liver Cancer (BCLC) staging system. While this system takes into account helpful factors such as liver function, performance status, and tumor burden, it fails to fully capture the true heterogeneity of the HCC patient population. Additional considerations include tumor biology, response to previous treatments, and the location of metastases. The specialists then share their experiences in treating patients with comorbid gastrointestinal cancers and mixed tumors, discuss the benefits of an interventional oncology clinic setting, and highlight virtual opportunities for connecting with tumor boards. They also offer advice on patient education regarding treatment options. --- TIMESTAMPS 00:00 - Introduction to BCLC Staging 03:02 - Impact of Performance Status 06:29 - Predictors of Survival in HCC 09:51 - Palliative versus Curative Treatment Intent 13:55 - Comorbid and Mixed Gastrointestinal Cancers 16:51 - Adverse Effects of Treatment 20:37 - Interventional Oncology in the Clinic Setting 23:06 - Navigating Multiple Provider Viewpoints 28:01 - Complex Case Examples --- RESOURCES BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update (Reig et al, 2022): https://www.journal-of-hepatology.eu/article/S0168-8278(21)02223-6/fulltext CME Accreditation Information: https://f7cae4ec-b69e-490d-9e0f-19b16a6f146d.usrfiles.com/ugd/f7cae4_a7c37ea3cd1b4d3fa53d5edf8dfe255b.pdf

In week two, host Paul Wirkus, MD, FAAP, and Jeremy Hendrick, MD, will discuss how comorbid issues impact mood disorders.  Have a question? Email questions@vcurb.com. Your questions will be answered in week four.For more information about available credit, visit vCurb.com.ACCME Accreditation StatementThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Colorado Medical Society through the joint providership of Kansas Chapter, American Academy of Pediatrics and Utah Chapter, AAP.  Kansas Chapter, American Academy of Pediatrics is accredited by the Colorado Medical Society to provide continuing medical education for physicians. AMA Credit Designation StatementKansas Chapter, American Academy of Pediatrics designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME credits: 0.75 Valid until: 15-09-2025 Claim your CME credit at https://reachmd.com/programs/cme/hf-management-for-patients-with-comorbid-conditions/27020/ Heart failure (HF) represents a significant burden on healthcare systems worldwide, with its prevalence steadily rising due to aging populations and increasing rates of comorbidities such as diabetes and chronic kidney disease. Despite advances in medical science, gaps persist in the identification, diagnosis, and management of heart failure among healthcare providers, particularly in the cardiology and primary care settings. This accredited microlearning program highlights key topics in HF in video episodes that are 7-10 minutes each. Each microlearning features peer-to-peer interviews or panel discussions with leading experts in the following episodes: (1) Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression; (2) Partnering with Patients: Building Effective Communication and Support in HF Care; (3) A Practical Guide to Prescribing in HF; (4) HF Management for Patients with Comorbid Conditions; (5) Level Up Your Skills: Tailoring Management of HF.

OCD doesn't like to show up alone. In fact, it often brings “friends” along — other mental health conditions that can tag along and make life even more challenging. This is called comorbid OCD. In today's video, we're going to dive into the most common conditions that often accompany OCD and what that means for those who are managing it.  0:00 What is comorbid OCD2:02 Tic Disorders2:37 Hoarding3:13 Trichotillomania3:59 Excoriation disorder 4:23 Depression5:30 Anxiety6:48 PTSD7:17 Phobia8:09 Social anxiety disorder9:13 Generalized anxiety disorder 10:17 It's NOT schizophrenia 11:50 Treating these conditions Follow us on social media:https://www.instagram.com/treatmyocd/https://twitter.com/treatmyocdhttps://www.tiktok.com/@treatmyocd

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on Particulate matter-2.5 pollution impact on comorbid cancer and cardiovascular disease mortality in the United States

In this week's podcast, Neurology Today's editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.

Introduction:In this insightful episode, we welcome Dr. Suzanne Goh, a pediatric neurologist and behavior analyst, to discuss the complexities of comorbid diagnoses in children with autism. Dr. Goh shares her expertise on the role of pediatric neurology, the importance of a holistic approach, and how parents can better advocate for their children.Guest: Dr. Suzanne GohDr. Suzanne Goh is a renowned pediatric neurologist and behavior analyst based in San Diego, California. Specializing in autism, Dr. Goh leads a comprehensive practice that integrates medical, behavioral, and developmental care. As the founder of Cordica, a network of 24 centers providing autism care services nationwide, she is dedicated to improving the lives of neurodivergent children and their families. Dr. Goh is also an author, with her latest book, "Magnificent Minds," offering a holistic approach to autism care.Key Points and Takeaways:Dr. Suzanne Goh's Background: Pediatric neurologist and behavior analyst specializing in autism.Shortage in the Field: There is a significant shortage of professionals specializing in pediatric neurology and autism care.Role of Pediatric Neurologists: Diagnosis, genetic testing, metabolic testing, and epilepsy management.Neurobehavioral Framework: Combining neurology and behavior analysis for a customized approach to autism care.Common Comorbid Diagnoses:Medical Conditions: Genetic, metabolic disorders, epilepsy, sleep disorders, gastrointestinal issues, immune disorders, and autonomic nervous system dysfunction.Impact of Comorbid Conditions: These can significantly affect a child's health, quality of life, learning, and well-being.Advocating for Your Child: The importance of looking deeper than just the autism diagnosis and finding the right medical team.Relevant Links:Cordica CareDr. Suzanne Goh's WebsiteMagnificent Minds Book on AmazonQuotes and Highlights:"The source of behavior is the brain. So it's a natural connection. And how can we really understand behavior if we're not thinking about the brain?""About 90% of autistic individuals have at least one co-occurring condition and 50% have four or more."About Rob Gorski and The Autism Dad podcast:Rob Gorski is a single Dad to three amazing autistic boys and the Founder and CEO of The Autism Dad, LLC. Multiple award-winning blogger, podcaster, content creator, social media influencer, and respected public figure for the last 15 years. Connect with Rob: theautismdad.comIf you found this episode helpful, please subscribe to our podcast, leave a review, and visit our website for more resources. Connect with us on social media to stay updated on future episodes.Mentioned in this episode:Learn More: GoallyThe Goally tablet is focused on fostering independence in kids without the distractions of ads, social media, or potentially harmful content. Unlike Kindle and iPad tablets, Goally's Tablet exclusively features educational apps like Khan Academy, Duolingo ABC, and Starfall, and is entirely controlled by parents. Goally's Kids Calendar helps kids with things like task management. Kids also learn life skills through video classes and pre-made routines,...

A Precision Health Approach Post-Treatment Comorbid Diabetes in Cancer With Marilyn Hammer by i3 Health

In this episode, Dr. David Goodman addresses your unanswered questions from his presentation, Setting the Mood: Strategies for Diagnosing and Treating ADHD in the Context of Bipolar Disorder, delivered at 2024 NEI Synapse in Las Vegas, Nevada.

Despite being serious mental health conditions, and highly comorbid with ADHD, eating disorders often go undetected. Christine Peat, Ph.D., helps caregivers and others understand symptoms and treatments for different types of eating disorders. Eating Disorders: More Resources Get: The Eating Disorders Linked to ADHD Self-Test: Eating Disorders in Adults Read: Body Image, Bigorexia, and Eating Disorders in Men and Boys Read: Red Flags and Recovery Steps for Teens Access the video and slides for podcast episode #494 here: https://www.additudemag.com/webinar/eating-disorders-adhd-arfid-anorexia/ Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.

Thanks for joining us at "The Art of Medicine with Dr. Andrew Wilner." My special guest today is Ilona Phillips, a therapist and founder of Lotus Consulting in Ann Arbor, MI. Ms Phillips specializes in treating addiction disorders, anxiety, and eating disorders. She has a particular interest in treating young people with eating disorders. During this 20-minute program, we discuss anorexia, bulimia, Avoidant Restrictive Food Intake Disorder (ARFIT), body dysmorphic disorders, and more. One of Ilona's treatment approaches is dialectical behavior therapy. She offers courses that teach parents how to help their child with an eating disorder. Comorbid psychiatric conditions also need to be identified and addressed. For more information on Lotus Consulting:https://lotusconsultingpllc.com/what-we-do/founder-ilona-phillips/ To contact Ilona, please check out her website: www.ilonaphillips.comIf you enjoy an episode, please share with friends and colleagues. "The Art of Medicine with Dr. Andrew Wilner" is now available on Alexa! Just say, "Play podcast The Art of Medicine with Dr. Andrew Wilner!" To never miss a program, subscribe at www.andrewwilner.com. You'll learn about new episodes and other interesting programs I host on Medscape.com, ReachMD.com, and RadioMD.com. Please rate and review each episode. To contact Dr. Wilner or to join the mailing list: www.andrewwilner.com To support this program: https://www.patreon.com/andrewwilner Finally, this production has been made possible in part by support from “The Art of Medicine's” wonderful sponsor, Locumstory.com, a resource where providers can get real, unbiased answers about locum tenens. If you are interested in locum tenens, or considering a new full-time position, please go to Locumstory.com. Or paste this link into your browser: ...

Earn CE credit here⁠⁠⁠⁠⁠. ⁠This program has been approved for 1 clock hour of continuing education credit by the Texas Speech-Language-Hearing Association (TSHA). TSHA approval does not imply endorsement of course content, specific products, or clinical procedures. TSHA CEU hours can be used as professional development hours for the maintenance of your ASHA certificate of clinical competence (CCC).  Listen, buy quiz (just $8), earn your speech pathology CE certificate of completion! Description: This course defines signs of dyslexia, the SLPs role when it comes to dyslexia identification and intervention, and discusses ways to work on speech and language goals with kids with dyslexia. Earn 1 clock hour of continuing education credit (Introductory Level, Professional Area). As a result of this presentation the participant will be able to:   1. List 5 overarching signs of dyslexia2. List 3 comorbid diagnoses with dyslexia3. Define the SLPs role when it comes to dyslexia identification and intervention4. Describe 5 strategies to use when working on speech therapy goals with kids with dyslexia Course presenters: Liz Vanderbrouk M.S. CCC-SLP Michelle Andrews M.S., CCC-SLP. Financial disclosures: Michelle Andrews' financial disclosers include: She has a ⁠⁠⁠⁠⁠⁠⁠⁠⁠Teachers pay Teachers⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠Boom Learning⁠⁠⁠⁠⁠⁠⁠⁠⁠, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠Teach with Medley⁠⁠⁠⁠⁠⁠⁠⁠⁠ store under Pep Talk LLC. She is also the founder and manager of the Pep Talk Podcast.  Michelle Andrews' non-financial disclosures include: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Speech Arcade⁠⁠⁠⁠⁠⁠⁠⁠⁠ is an in-kind sponsor for this podcast. Liz's financial disclosures: She has a T P T store as well as her own website, the speech therapist.ch, where she sells her activities. Liz's non-financial disclosures: She is the founder of the speech therapist ch in Switzerland. Agenda: 5 min: Introduction, bio, disclosures, learner objectives 15 min: Signs of Dyslexia 10 min: Comorbid diagnoses 15 min: SLPs role when it comes to Dyslexia 10 min: Strategies for speech therapy 5 min: Summary, closing points References and resources: ⁠⁠⁠⁠⁠⁠⁠⁠⁠click here⁠⁠⁠⁠⁠⁠⁠⁠⁠ A transcript is available for this podcast course.⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to read the transcript⁠.⁠⁠⁠⁠ ⁠⁠⁠⁠If you need any additional accommodations please email info@peptalkpodcastforslps.com Disclaimer: Pep Talk LLC does not imply endorsement of course content, specific products, or clinical procedures. --- Support this podcast: https://podcasters.spotify.com/pod/show/michelle-andrews85/support

In this episode, Dr. Jeffrey Strawn addresses your unanswered questions from his presentation, Along for the Ride: Treatment Considerations for Childhood Psychiatric Disorders With Co-Occurring Anxiety, at the Child & Adolescent Psychiatry Academy.

Cluster B This show aims to educate the audience from a scientifically informed perspective about the major cluster B personality disorders: narcissism, histrionic, borderline, and antisocial. Want more mental health content? Check out our other Podcasts: Mental Health // Demystified with Dr. Tracey Marks  True Crime Psychology and Personality Healthy // Toxic Here, Now, Together with Rou Reynolds References:  Jakes S, Rhodes J, & Issa S. (2004). Are the themes of delusional beliefs related to the themes of life-problems and goals? Journal of Mental Health, 13(6), 611–619. Retrieved from http://search.ebscohost.com.mylibrary... Rhodes, J., Jakes, S., & Robinson, J. (2005). A qualitative analysis of delusional content. Journal of Mental Health, 14(4), 383–398. https://doi-org.mylibrary.wilmu.edu/1... Siddle, R., Haddock, G., Tarrier, N., & Faragher, E. B. (2002). Religious delusions in patients admitted to hospital with schizophrenia. Social Psychiatry and Psychiatric Epidemiology: The International Journal for Research in Social and Genetic Epidemiology and Mental Health Services, 37(3), 130–138. https://doi-org.mylibrary.wilmu.edu/1... Saavedra, J. (2014). Function and meaning in religious delusions: a theoretical discussion from a case study. Mental Health, Religion & Culture, 17(1), 39–51. https://doi-org.mylibrary.wilmu.edu/1... Iyassu, R., Jolley, S., Bebbington, P., Dunn, G., Emsley, R., Freeman, D., … Garety, P. (2014). Psychological characteristics of religious delusions. Social Psychiatry and Psychiatric Epidemiology: The International Journal for Research in Social and Genetic Epidemiology and Mental Health Services, 49(7), 1051–1061. https://doi-org.mylibrary.wilmu.edu/1... Torgalsbøen, A.-K. (1999). Comorbidity in schizophrenia: A prognostic study of personality disorders in recovered and non-recovered schizophrenia patients. Scandinavian Journal of Psychology, 40(2), 147–152. https://doi-org.mylibrary.wilmu.edu/1... Volavka, J. (2014). Comorbid personality disorders and violent behavior in psychotic patients. Psychiatric Quarterly, 85(1), 65–78. https://doi-org.mylibrary.wilmu.edu/1... Bo, S., Forth, A., Kongerslev, M., Haahr, U. H., Pedersen, L., & Simonsen, E. (2013). Subtypes of aggression in patients with schizophrenia: The role of personality disorders. Criminal Behaviour and Mental Health, 23(2), 124–137. https://doi-org.mylibrary.wilmu.edu/1... Chun, C. A., Barrantes-Vidal, N., Sheinbaum, T., & Kwapil, T. R. (2017). Expression of schizophrenia-spectrum personality traits in daily life. Personality Disorders: Theory, Research, and Treatment, 8(1), 64–74. https://doi-org.mylibrary.wilmu.edu/1... Nieto-Rucian, V., & Furness, P. J. (2019). The experience of growing up with a parent with schizophrenia—A qualitative study. Qualitative Psychology, 6(3), 254–267. https://doi-org.mylibrary.wilmu.edu/1... Cook, C. Religious psychopathology: The prevalence of religious content of delusions and hallucinations in mental disorder. International Journal of Social Psychiatry2015, Vol. 61(4) 404 –425 DOI: 10.1177/0020764015573089 https://www.ncbi.nlm.nih.gov/pmc/arti... Thibodeau, R., & Principino, H. M. (2019). Keep your distance: People sit farther away from a man with schizophrenia versus diabetes. Stigma and Health, 4(4), 429–432. https://doi-org.mylibrary.wilmu.edu/1... (Supplemental) Links for Dr. Grande Dr. Grande on YouTube Produced by Ars Longa Media Learn more at arslonga.media. Produced by: Erin McCue Executive Producer: Patrick C. Beeman, MD Legal Stuff The information presented in this podcast is intended for educational and entertainment purposes only and is not professional advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.07.12.547253v1?rss=1 Authors: Rawls, E., Marquardt, C., Fix, S., Bernat, E., Sponheim, S. Abstract: Objective: More than half of US military veterans with posttraumatic stress disorder (PTSD) are dependent on alcohol which complicates efforts to optimize treatment. To understand brain mechanisms that could explain this disabling comorbidity, we investigated how brain responses to negative experiences were related to the clinical symptomatology of PTSD and prevalence of alcohol use). Methods: We recorded electroencephalography responses to unpredictable gain/loss feedback in veterans who had been deployed to war zones as part of Operations Enduring or Iraqi Freedom (OEF/OIF). We applied time-frequency principal components analysis to event-related potentials (ERPs) to isolate neural responses to gains and losses, identifying a frontal theta-band component reflecting primarily losses (feedback-related negativity, FRN). Results: The severity of intrusive reexperiencing of traumatic events was associated with enhanced mediofrontal theta signaling during loss, which suggests an increased salience for negative outcomes. At the same time, increased hazardous alcohol use was associated with reduced mediofrontal theta signaling following loss. Thus, enhanced salience signaling during losses was linked to reexperiencing symptoms, while alcohol use may have functioned as a negative reinforcer by maladaptively reducing such salience signaling. Conclusions: A shared neural mechanism appears to underlie co-occurring posttraumatic stress and hazardous alcohol use and highlights the potential for interventions targeting mediofrontal theta signaling to improve the functioning of individuals experiencing these conditions. Future clinical interventions that target mediofrontal theta might modulate exaggerated negative salience processing and effectively reduce trauma-related psychopathology and the draw of alcohol consumption. Copy rights belong to original authors. Visit the link for more info Podcast created by Paper Player, LLC

Major Depressive Disorder (MDD) is highly comorbid with ADHD. Learn about symptoms of mood disorders, how they co-exist with ADHD, and about new and alternative treatments for depression from Nelson M. Handal, M.D., DFAPA.

Natasha A. Mesinkovska, MD, PhD, who spoke on the live satellite symposium "Gamechangers in Alopecia Areata" at the SBS 2023 meeting, speaks out about comorbid conditions often seen in alopecia areata patients, as well as her personal approach to treatment. Questions: We've heard a lot about comorbid conditions often seen in patients with alopecia areata. Do you have any pearls you'd like to share regarding screening or multidisciplinary care for patients with comorbidities? What is your personal approach to developing a treatment plan for your patients with alopecia areata?  Thank you for your time today, Dr Mesinkovska. This was very informative. Is there anything else you'd like to add?   Date: February 10, 2023

An article was published in the ERJ demonstrating that CBT for Insomnia reduced the severity of obstructive sleep apnea. Our guest, Dr. Alexander Sweetman, is here to tell us more.

In this episode of CUBIST, Amanda, and Don discuss the article, "Cognitive behavioral therapy for veterans with comorbid post-traumatic headache and post-traumatic stress disorder symptoms: A randomized clinical trial" by Donald McGeary and colleagues and published in JAMA Neurology in August of 2022. Article Citation: McGeary, D. D., Resick, P. A., Penzien, D. B., McGeary, C. A., Houle, T. T., Eapen, B. C., Jaramillo, C. A., Nabity, P. S., Reed, D. E., 2nd, Moring, J. C., Bira, L. M., Hansen, H. R., Young-McCaughan, S., Cobos, B. A., Mintz, J., Keane, T. M., & Peterson, A. L. (2022). Cognitive Behavioral Therapy for Veterans With Comorbid Posttraumatic Headache and Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA neurology, 79(8), 746–757. https://doi.org/10.1001/jamaneurol.2022.1567 Article LINK: https://pubmed.ncbi.nlm.nih.gov/35759281/ CUBIST is a podcast for healthcare providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views, opinions, and/or findings in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy, or decision unless designated by other official documentation. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.

Comorbid Conditions in the Patient with Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/37727 LEARNING OBJECTIVES: At the conclusion of these activities, participants will be able to: 1. Oversee comorbidities and describe their management in the context of advanced prostate cancer treatment. 2. Assess the potential cardiovascular risk associated with ADT. 3. Differentiate the roles of the urologist, other specialists and advanced practice providers and identify opportunities for shared care and team-based approaches of patients with prostate cancer. ACKNOWLEDGEMENTS: This series is supported by independent educational grants from: Myovant Sciences LTD Pfizer, Inc.

In this episode of CUBIST, Amanda, and Don discuss the article, "Cognitive behavioral therapy for veterans with comorbid post-traumatic headache and post-traumatic stress disorder symptoms: A randomized clinical trial" by Donald McGeary and colleagues and published in JAMA Neurology in August of 2022. Article Citation: McGeary, D. D., Resick, P. A., Penzien, D. B., McGeary, C. A., Houle, T. T., Eapen, B. C., Jaramillo, C. A., Nabity, P. S., Reed, D. E., 2nd, Moring, J. C., Bira, L. M., Hansen, H. R., Young-McCaughan, S., Cobos, B. A., Mintz, J., Keane, T. M., & Peterson, A. L. (2022). Cognitive Behavioral Therapy for Veterans With Comorbid Posttraumatic Headache and Posttraumatic Stress Disorder Symptoms: A Randomized Clinical Trial. JAMA neurology, 79(8), 746–757. https://doi.org/10.1001/jamaneurol.2022.1567 Article LINK: https://pubmed.ncbi.nlm.nih.gov/35759281/ CUBIST is a podcast for healthcare providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views, opinions, and/or findings in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy, or decision unless designated by other official documentation. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.

Did you know that musculoskeletal care is one of the biggest challenges facing the value transformation of healthcare?  Musculoskeletal healthcare spending is rising at an unsustainable rate – having doubled in the last decade!  Many of these procedures (such as knee replacements and spinal fusions) contribute to overspending on care that is not even needed, as it has been estimated that only 50% of MSK procedures are evidence-based. The rising costs ofmusculoskeletal care is now a top cost driver for employers and health plans. Yet despite rising costs, MSK outcomes for members haven't gotten better over the last ten years. Studies have shown that, despite a dramatic increase in health care expenditures for patients with back and neck problems over the last decade, there has not been a corresponding improvement in patient clinical outcomes. In short, spending more money has not correlated with better outcomes.  We are in dire need of a value-based revolution in the provision of musculoskeletal care. The current system is clearly broken. Studies have demonstrated that common approaches to MSK care (surgery, imaging, injections, opioids) do not effectively resolve back and joint pain. And the challenges of escalating costs associated with such low value are too big to ignore. There is a better way, and this week on the Race to Value, we interview two of the leading innovators in orthopedic value-based care! In this special episode, we will begin with an interview with Dr. Kevin Bozic, the chair of surgery and perioperative care at the Dell Medical School at The University of Texas at Austin. He is an internationally recognized leader in orthopedic surgery and value-based health care payment and delivery models and currently serves on the Board of Directors for the American Academy of Orthopaedic Surgeons – a clear signal from the AAOS that the specialty is moving into the value-based care arena. Our second interview on the podcast is with Dr. Kian Raiszadeh, the CEO and Co-Founder of Livara and SpineZone, an orthopedic surgeon who has created an innovative orthopedic care management system for payors, providers, and health systems to unify the patient experience and transition to orthopedic value-based care. Episode Bookmarks: 01:30 Musculoskeletal healthcare spending is rising at an unsustainable rate – having doubled in the last decade! 01:45 It has been estimated that only 50% of MSK procedures are evidence-based. 02:00 Increased MSK spending in healthcare not associated with a corresponding improvement in patient clinical outcomes. 03:00 Introduction to Kevin Bozic, M.D., MBA and Kian Raiszadeh, M.D. 03:45 Upcoming conference in value-based orthopedics – OVBC on January 26th-28th 05:00 At the Musculoskeletal Institute at UT Health Austin, Dr. Bozic has created a MSK Integrated Practice Unit. 06:30 Dr. Bozic provides an overview of the Musculoskeletal Institute and how it functions as an Integrated Practice Unit. 07:30 “The vast majority of patients with musculoskeletal conditions do not require or benefit from surgery.” 08:00 The role of the primary care in treating MSK disease within a “musculoskeletal medical home”. 08:45 Comorbid conditions with chronic MSK disease (e.g. anxiety, depression, obesity) are rarely treated in a non-integrated model. 09:45 Holistic integration of primary care-based orthopedic physicians, APPs, physical therapists, dieticians, and social workers. 12:30 Dr. Bozic discusses the potential for condition-based bundled payments in the treatment of MSK disease. 13:45 The role of bundled payment care pathways in lowering overall costs with better clinical outcomes. 14:00 How reduction of inpatient post-acute care can result in lower episode spend with “no detrimental impact on patient outcomes.” 15:00 The big value opportunity -- addressing the continuum of care across the spectrum of disease (not just focusing on the surgery). 16:00 Redesigning MSK delivery for optimizing outcome...

Interview with Francis Vergunst, DPhil, and Massimilliano Orri, PhD, authors of Association of Childhood Externalizing, Internalizing, and Comorbid Symptoms With Long-term Economic and Social Outcomes. Hosted by Angel N. Desai, MD, MPH. Related Content: Association of Childhood Externalizing, Internalizing, and Comorbid Symptoms With Long-term Economic and Social Outcomes

On today's episode we are talking about the latest on Elon Musk, the tridemic, a new IRS rule, and January 6th. Time Stamps: 12:13 Elon Musk 28:50 Tridemic 41:58 IRS gone wild 48:59 J6 Email us at Hammered@Nebulouspodcasts.com

In this episode, I talked with Brooke Miller, a mental health/OCD advocate, registered nurse, wife, and mom who opens up about her struggles with OCD, eating disorders, panic disorder, and bipolar disorder. We discussed... - her experience with these comorbidities and how they presented and affected her - why she thinks OCD was at the center and root of other diagnoses - what recovery looks like for her and how she learned to sit with discomfort and uncertainty You can learn more about Brooke and follow her on Instagram/TikTok at @brookemillermha www.smashingstigmas.com This podcast should not be substituted, nor is meant to act as a substitute, for legitimate mental health treatment/a legitimate mental health treatment provider. This podcast and any information in it is solely the reflection of general knowledge and cannot be taken as a personal therapeutic recommendation. To find a therapist near you to work more directly with these issues, head over to treatmyocd.com, IOCDF.org, or nami.org. Support this podcast: https://anchor.fm/jennaoverbaugh/support --- Support this podcast: https://anchor.fm/jennaoverbaugh/support

You receive a letter from an old friend. He isn't doing well. He invites you to visit him at his house. His house...that's eating him whole. Today's episode was inspired by "The Fall of the House of Usher" by Edgar Allan Poe.  

Recording of the Evidence Based Hair Podcast for the Oct 11, 2022 issue.  TINEA CAPITIS STUDIES Cukierman E et al (starts at 5:18). Alopecia and pet: a case report. Einstein (Sao Paulo). 2022 Jul 4;20:eRC6881.   TELOGEN EFFLUVIUM - COVID 19 Visconti A et al (starts at 20:00) Cutaneous Manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348,691 UK users of the UK ZOE COVID Study App. Br J Dermatol. 2022 Jul 22;   TELOGEN EFFLUVIUM - ISOTRETINOIN Tran PT et al (starts at 29:30) Characteristics of Patients with Hair Loss after Isotretinoin Treatment: A Retrospective Review Study. Int J Trichology. 2022 Jul-Aug;14(4):125-127.   TRICHOTILLOMANIA STUDIES Grant JE and Chamberlain SR (starts at 42:17). Natural recovery in trichotillomania. Aust N Z J Psychiatry. 2022 Oct;56(10):1357-1362   Chesivoir EK et al (starts at 47:30). Comorbid trichotillomania and attention deficit hyperactivity disorder in adults. Psychiatry. 2022 Jul; TELOGEN EFFLUVIUM -   IRON DEFICIENCY   Kano Y. Blue sclera (starts at 55:33): An overlooked finding of iron deficiency. Cleve Clin J Med. 2022 Oct 3;89(10):549-550.    

Welcome to Season 4 of the FASD Family Life Podcast. the show for families by families raising children and youth with Fetal Alcohol Spectrum Disorder. I am your host, Robbie Seale. I am an FASD educator, advocate and mom of five incredible people; including three teens diagnosed with Fetal Alcohol Spectrum Disorder. If my 30 years of parenting has taught me anything it is, that the struggle is real and so is success.This podcast is supported by listeners like you!  Click here to Support the show Sept 30 is the National Day for Truth and ReconciliationOrange Shirt Day Orange Shirt Day - WikipediaFor more information about the National Centre for Truth and Reconciliation, click hereDid you catch last week's episode featuring the ever-inspiring Lauren Richardson to talk about her advocacy work as an individual with FASD and her dream to open a Centre for FASD in her community that would provide FASD training, support, resource connections, and a place of belonging for individuals with Fetal Alcohol Spectrum Disorder and their families. Support Lauren's dream by donating https://www.gofundme.com/f/fetal-alcohol-awareness-campaign-September-9-2022SUBSCRIBE now so you never miss another episode.WANT TO MEET OTHER PARENTS RAISING KIDS WITH FASD?Subscribe to the FASD Family Life Community for only $20 / monthYou will be invited to join our monthly online support group on Microsoft Teams.Our support group is a fun, lively place to connect with other parents who get it.SIGN UP TODAY to be part of our next meetinghttps://paypal.me/FASDFamilyLife?country.x=CA&locale.x=en_USMany of my listeners have written and to asked me to talk about the many health issues faced by our loved ones with FASD.  I met with three experts who join in in this episode to tackle the important conversation about comorbid physical and mental health issues that often present alongside FASD.  My guests on this episode are Myles Himmelreich, Emily Hargrove, and CJ Lutke, each one has firsthand experience with this reality. Each of my guests has a diagnosis of FASD as well as a long list of medical diagnosis and challenges as a result of prenatal alcohol exposure.  Myles, CJ< and Emily are members of the Adult Leadership Committee of the FASD Changemakers, lead researchers and authors of The lay of the land: fetal alcohol spectrum disorder (FASD) as a whole-body diagnosis study. Join us as we discuss their groundbreaking research that led to the discovery of the 428 comorbid conditions common with FASD.  You will be awed by their strength and tenacity when you hear their joy, enthusiasm and zest for life. The lay of the land: fetal alcohol spectrum disorder (FASD) as a whole-body diagnosis study was published in the Routledge Handbook for Social Workers and Addictive Behavior. https://www.routledge.com/The-Routledge-Handbook-of-Social-Work-and-Addictive-Behaviors/Begun-Murray/p/book/9781032336619Email: fasdfamilylife@gmail.com   LIKE & SHARE on your socialsSupport the show

How to untangle pediatric OCD from ASD and GAD? This episode discusses pediatric OCD and its comorbidities: Depression, GAD, and ASD. It includes a discussion on the differences in concerns between OCD and GAD, the assessment of primary and secondary depressive symptoms, and the differences between ASD and OCD rituals.  Faculty: David Rosenberg, M.D.  Host: Jessica Diaz, M.D. Learn more about Premium Membership here Earn 1 CME: OCD in Children and Adolescents Pediatric OCD Comorbidity With Depression, Anxiety Disorders, and ASD

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. In this episode, we present a broad overview of antisocial personality disorder and psychopathy with our guest expert - Dr. Donald Lynam. Dr. Lynam is a clinical psychologist by training, and professor at Purdue university, where he heads the Purdue's Developmental Psychopathology, Psychopathy and Personality Lab. While there may be some disagreement in the field, Dr. Lynam and I discuss how ASPD and psychopathy are two diagnostic constructs that are attempting to outline the same psychopathology, with the main difference being the degree of severity - for this reason, we use the terms antisocial and psychopathic interchangeably.    While not necessary, it may be of benefit for listeners to familiarize themselves with the DSM-V criteria for antisocial personality disorder, the psychopathy checklist (PCL), as well as the 5-factor model of personality. References for each are listed below in the references section, however, for a brief overview, one could do a quick google image search for each term (Wikipedia also has a succinct overview of the psychopathy checklist).   The learning objectives for this episode are as follows:   Develop a basic understanding of what is meant by antisocial personality and psychopathy Be aware of some of the classic traits and characteristics of antisocial/psychopathic personalities, and the general functions of these behaviors  Describe the theoretical basis for the development of antisocial personalities    Guest Expert: Dr. Donald Lynam - Clinical psychologist, Investigator at Purdue University, Indiana Produced and hosted by: Dr. Chase Thompson (PGY5 in Psychiatry) Episode guidance and feedback: Dr. Gaurav Sharma (PGY4 in Psychiatry)   Interview Content:   0:50 - Learning objectives 1:40 - Dr. Lynam discusses his path to his current research interests 3:40 - Defining the terms antisocial personality disorder, sociopathy, psychopathy 8:30 - Discussing the possibility of antisocial behaviors without an antisocial personality 12:07 - Laying out the core features of antisocial individuals  18:20 - Antisocial personality from the perspective of the Big 5 personality model 22:00 - Discussion of the high-functioning psychopathy  25:06 - Prevalence of psychopathy 30:10 - Factors relevant to the development of psychopathy 39:30 - Prognosis and clinical trajectory  44:30 - Comorbid psychopathology  46:30 - Functions of antagonism or antisocial behaviours  49:30 - Treatment    References   American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013. Broidy LM, Nagin DS, Tremblay RE, Bates JE, Brame B, Dodge KA, Fergusson D, Horwood JL, Loeber R, Laird R, Lynam DR. Developmental trajectories of childhood disruptive behaviors and adolescent delinquency: a six-site, cross-national study. Developmental psychology. 2003 Mar;39(2):222. Babiak P, Hare RD, McLaren T. Snakes in suits: When psychopaths go to work. New York: Harper; 2007 May 8. Hare RD. The psychopathy checklist–Revised. Toronto, ON. 2003;412. Hare RD, Harpur TJ, Hakstian AR, Forth AE, Hart SD, Newman JP. The revised psychopathy checklist: reliability and factor structure. Psychological Assessment: A Journal of Consulting and Clinical Psychology. 1990 Sep;2(3):338. Hare RD, Hart SD, Harpur TJ. Psychopathy and the DSM-IV criteria for antisocial personality disorder. Journal of abnormal psychology. 1991 Aug;100(3):391. Jones SE, Miller JD, Lynam DR. Personality, antisocial behavior, and aggression: A meta-analytic review. Journal of Criminal Justice. 2011 Jul 1;39(4):329-37. Lynam DR. Early identification of chronic offenders: Who is the fledgling psychopath?. Psychological bulletin. 1996 Sep;120(2):209. Miller JD, Lynam DR. Psychopathy and the five-factor model of personality: A replication and extension. Journal of personality assessment. 2003 Oct 1;81(2):168-78.   CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association. For more PsychEd, follow us on Twitter (@psychedpodcast), Facebook (PsychEd Podcast), and Instagram (@psyched.podcast). You can provide feedback by email at psychedpodcast@gmail.com. For more information, visit our website at psychedpodcast.org.

In this episode, I touch on the topic of Comorbid Diagnosis before telling you a bit about my own journey to getting diagnosed as Autistic. Research estimates that 50-96% of people with BPD are living with a comorbid mental health condition, whether that is depression or anxiety, other mood disorders, or even substance abuse issues (to name a few). Understanding how to treat these comorbid diagnosis can be integral to our understanding of what BPD means for us, as we can get the treatment we need to be able to handle the emotional rollercoaster that BPD is. In regards to my Autism Journey, I talk about what my testing process was like, how long it took, and also the cost, because where I live, most adult services for Autism testing is paid out of pocket which makes it highly inaccessible for many people. I am thankful to those who have spent their time sharing their own autism stories as that is what prompted me to want to get tested, and am thankful for you to give me the space to talk about what it's like now living with both BPD and Autism. Life can feel incredibly lonely sometimes so I thank you for giving me the space to unpack my own mental health. As always, feel free to reach out if you liked this episode or relate to what I've spoken about @journey.bound in instagram and be kind to yourself

What is comorbid chaos, how is it different from other types of chaos, and what are its consequences for societies and individuals? Doc explains the markers of uncertain times and reads an excerpt from his book, The Velocity of Information: Human Thinking During Chaotic Times. COMORBID CHAOS. (Pages 144-45) “This fourth state of chaos includes qualities of Extended and International chaos events with the addition of one or more secondary, population-level chaos events that are intermediate and regional or extended and international. The secondary event happens concurrently with some or the entire primary event. In addition, chaos at this level oscillates in intensity. For example, there may be civil unrest affected by weather patterns (e.g., protests taper off on rainy days). Populations exhibit a lack of trust in government and authority. There is a corresponding loss of credibility by those in authority due to changing narratives.” EXAMPLES OF COMORBID CHAOS. Examples of comorbid chaos include The Great Depression from 1929 to 1939 confounded by the 1931–1939 Great Plains Dust Bowl and the 2020 COVID-19 pandemic in conjunction with racial justice protests. THE GREAT DEPRESSION. The Great Depression was the worst economic downturn in the history of the industrialized world, lasting from 1929 to 1939. In 1932, many politicians, businessmen, and journalists started to contemplate the possibility of massive revolution in the United States. In fact, thousands of the most desperate unemployed workers began raiding food stores (1). By 1933, when the Great Depression reached its lowest point, some fifteen million Americans were unemployed and nearly half the country's banks had failed (2). Economic stability gradually returned in 1939 due, in part, to government New Deal projects that reformed financial systems and put people back to work. Many people who lived through the era distrusted banks and would no longer buy goods using credit. THE DUST BOWL. But before the economic improvement, the Dust Bowl intensified the crushing economic impacts of the Great Depression. In 1931, severe drought hit the Midwestern and Southern Plains of the United States. As crops died, crumbling topsoil from over-plowed and over-grazed land led to powerful dust storms that pummeled the region (3). “Residents crawled to safety in the dust (summer) storms and ‘snust' (winter) storms. Many towns were abandoned (4)” Hundreds of people succumbed to what doctors at the time called “dust pneumonia,” a respiratory illness caused by tiny inorganic particles in the windblown dust (5). Famine gripped the region as it was impossible to sustain livestock. “Cattle went blind and suffocated. When farmers cut them open, they found stomachs stuffed with fine sand (6).” RECENT EXAMPLES OF COMORBID CHAOS. Since March 2020, there have been two instances of comorbid chaos in the world. PANDEMIC AND SOCIAL JUSTICE PROTESTS. The epoch of March 2020 through January 2022 was marked by the pandemic as the primary event with episodic anti-racism demonstrations serving as the secondary event. INFLATION AND WORLD CONFLICT. The consumer price index climbed 7% in 2021, the largest 12-month gain since June 1982, according to Labor Department data. Gasoline prices also approached $5 a gallon in many parts of the United States. Inflation, which many pundits speculate to be higher and more severe than official statistics, brought further instability to the roaring housing market and faltering supply chain. On February 24, 2022, Russian invaded Ukraine, leading to military conflict, over 2 million people fleeing Ukraine, and widespread sanctions applied to Russia. The world was brought closer to the first use of nuclear weapons since World War II. CITATIONS: (1) Marx, Jerry D. “American Social Policy in the Great Depression and World War II.” VCU Libraries Social Welfare History Project. 2011. http://socialwelfare.library .vcu .edu /eras /great -depression /american -social -policy -in -the -great -depression-and -wwii. (2) History.com Editors, Great Depression History. (3) American Experience. “Surviving the Dust Bowl. Timeline: The Dust Bowl.” PBS. n.d. https://www .pbs .org /wgbh /americanexperience /features /dust -bowl -surviving-dust -bowl/. (4) Gordon, Dan. “When Deadly Dirt Devastated the Southern Plains.” The Denver Post. May 12, 2011. https://www .denverpost .com /2011 /05 /12 /when -deadly-dirt -devastated -the -southern -plains. (5) Williford, James. “Children of the Dust. The Dirty Thirties as Witnessed by People Who Were Actually There.” Humanities 33, no. 6. National Endowment for the Humanities. November/December 2012. https://www .neh .gov /humanities /2012 /novemberdecember /feature /children -the -dust (6) Gordon, Deadly Dirt. FOLLOW DR. PERRODIN: Twitter @SafetyPhD and www.safetyphd.com. The Safety Doc Podcast is hosted & produced by David P. Perrodin, PhD. This is episode 173 of The Safety Doc Podcast published on 03-15-2022. GET DOC'S BOOKS. Purchase the preeminent book of scholarship for an uncertain epoch from your favorite bookstore or online retailer and recommend it as a purchase for your local library! The Velocity of Information: Human Thinking During Chaotic Times (2022) by David P. Perrodin. Purchase Dr. Perrodin's Books: School of Errors – Rethinking School Safety in America. www.schooloferrors.com Velocity of Information - Human Thinking During Chaotic Times. www.velocityofinformation.com   

Links for Dr. Grande YouTube channel Dr. Grande's Patreon Want more mental health content? You might also be interested in these other Ars Longa podcasts: Mental Health // Demystified with Dr. Tracey Marks  Healthy // Toxic Ars Longa Media To learn more about us and this podcast, visit arslonga.media.  The information presented in this podcast is intended for educational purposes only and should not be construed as mental health advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week Lisa and Diana reconnect with Dr. Roberto Olivardia to learn about the connection between attention deficit hyperactivity disorder (ADHD) and eating disorders, and the unique implications for treatment that result from having this double diagnosis. Dr. Olivardia also shares his personal experiences about what it is like to have ADHD and work with it to lead a productive and fulfilling life.

This episode is also available as a blog post: https://mentalhealthaffairs.blog/the-value-of-good-complex-case-management-for-comorbid-psychiatric-issues/artpainting1982/self-help/ --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/max-guttman/message

Links for Dr. Grande YouTube channel Dr. Grande's Patreon Want more mental health content? You might also be interested in these other Ars Longa podcasts: Mental Health // Demystified with Dr. Tracey Marks  Healthy // Toxic Ars Longa Media To learn more about us and this podcast, visit arslonga.media.  The information presented in this podcast is intended for educational purposes only and should not be construed as mental health advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Kalaki Clarke, MD is a Board-Certified Family Physician who provides compassionate medical care for patients experiencing homelessness on Skid Row in Downtown, Los Angeles. She received her Medical degree in 2005 and she completed her Family Medicine in 2017. It was her personal experiences with Major Depressive Disorder and a late diagnosis of ADHD at age 35 which prompted her to additionally complete the UC Irvine/UC Davis' Primary Care Psychiatry Fellowship to provide greater mental health support for her patients. As a strong mental health advocate, Dr. Clarke serves as an Administrator of Physicians with ADHD, a private group of more than 500 physicians and is a member of the Society for Healthcare Professionals with Disabilities. In this video, Dr. Kalaki shares her ADHD journey and some of the struggles she had before getting diagnosed. She also defines what comorbidity means and how some can manage their comorbid diagnosis along with their ADHD. Her Resources: ■ IG: Dr. Kalaki Clarke ■ Other Resources: ■ American Psychiatry Association (APA) ■ ADDitude Magazine

Show notes for Episode 16:   For today's episode we will be reviewing three articles from the July-August 2020 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology. You can also earn CME credit by listening to this podcast! For information about CME credit or to read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch Please watch out for continued discussion on this topic in the ACAAI Community on DocMatter, we'll have key takeaways with the opportunity for ongoing conversation about today's topic! Article links: Prevalence and impact of comorbid laryngeal dysfunction in asthma: A systematic review and meta-analysis.   Trends and Disparities in Asthma Biologic Use in the United States.   Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.   Please rate our podcast on iTunes! Please give us feedback, corrections, and suggestions! Email feedback to: allergytalk@acaai.org ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced. Today's speakers have the following disclosures: Drs. Lee and Kalangara has nothing to disclose Dr. Fineman Speaker: AstraZenca, Boehringer Ingelheim, Shire; Research: Aimmune, DBV, Shire, Regeneron.

Medical anthropology may not be the first discipline we associate with public health, but it provides perspectives that are vital to understanding the many and complex intersections at the root of health disparities.

Medical anthropology may not be the first discipline we associate with public health, but it provides perspectives that are vital to understanding the many and complex intersections at the root of health disparities.